Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-Label Phase 1 Study to Evaluate PF-08046032 as Monotherapy and Part of Combination Therapy in Participants With Advanced Malignancies

NCT06870487 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT06870487
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06870487 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-Label Phase 1 Study to Evaluate PF-08046032 as Monotherapy and Part of Combination Therapy in Participants With Advanced Malignancies
Lead sponsor
Pfizer
Phase
Phase 1
Overall status
Terminated
Start date
May 8, 2025
Completion date
April 23, 2026
Enrollment
6 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

classical hodgkin lymphoma, diffuse large b-cell lymphoma, head and neck squamous cell carcinoma, melanoma, non-small cell lung cancer, peripheral t cell lymphoma